Individual provider · Type 1 NPI
Pablo Andres Ledesma Paredes, MD
Cardiovascular Disease Physician · Greensboro, NC
NPI number
1558999599
Active
Practice location
3903 N Elm St Ste 201
Greensboro, NC 27455-2878
Fax (336) 878-6531
Mailing address
Medical Center Blvd
Winston Salem, NC 27157-0001
Other practice locations
- Medical Center Blvd, Winston Salem, NC 27157-0001 · (336) 716-6674
- 81 Highland Ave, Salem, MA 01970-2768 · (978) 741-1200
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Internal Medicine Physician | 207R00000X | 2026-03311 (NC) |
| Student in an Organized Health Care Education/Training Program | 390200000X | None listed |
| Cardiovascular Disease Physician Primary | 207RC0000X | 2026-03311 (NC) |
Cardiovascular Disease Physician: An internist who specializes in diseases of the heart and blood vessels and manages complex cardiac conditions such as heart attacks and life-threatening, abnormal heartbeat rhythms.
3 other providers at this address
Other cardiovascular disease physician providers in Greensboro
- Gayatri A. Acharya, MDCardiovascular Disease Physician Greensboro, NC NPI 1013270248
- Richard Alan Weintraub, MD FACCCardiovascular Disease Physician Greensboro, NC NPI 1023116647
- John Michael Cahill, MDCardiovascular Disease Physician Greensboro, NC NPI 1063533875
- Brian Sanders Crenshaw, MDCardiovascular Disease Physician Greensboro, NC NPI 1093778227
- Stanley Neal Tennant, MDCardiovascular Disease Physician Greensboro, NC NPI 1134276413
- Jared Segal, DOCardiovascular Disease Physician Greensboro, NC NPI 1174057491
- Ajay S. Kadakia, MDCardiovascular Disease Physician Greensboro, NC NPI 1174619795
- Alfred Boyd Little, MD FACCCardiovascular Disease Physician Greensboro, NC NPI 1225134323
About NPI 1558999599
Pablo Andres Ledesma Paredes, MD's National Provider Identifier is 1558999599, issued on Mar 27, 2020. The primary taxonomy on file is Cardiovascular Disease Physician (207RC0000X), and the practice location is in Greensboro, NC. The record was last updated on Aug 25, 2026.